Over 25% of Ocular Complications From Dupilumab in Kids Developed After a Year

(MedPage Today) — ORLANDO — Among children taking the monoclonal antibody dupilumab (Dupixent) for atopic dermatitis, more than a quarter of ocular complications developed after a year, according to a retrospective cohort study.
Of the children…